Tendersinfo Gulf

Filter Search

Healthcare and Medical

Location Summary Deadline
Germany The Dak-gesundheit Is Entering Into A Non-exclusive Discount Agreement For The Active Ingredient Tocilizumab (only Pre-filled Syringe And Pre-filled Pen) For The Period From December 1, 2025, To November 30, 2027. This Procedure Is Expected To Fall Outsid 2026-04-16
Germany Conclusion Of Non-exclusive Discount Agreements In Accordance With Section 130a Paragraph. 8 Sgb V On The Active Ingredients Mentioned With The Possibility Of Contracting Within The Framework Of The So-called Openhouse Procedure. 2026-04-16
Germany Open House Drug Discount Agreements For The Active Ingredient Rotigotine, Atc N04bc09 2026-04-16
Germany Open House Drug Discount Agreements For The Active Ingredient Diltiazem, Atc C08db01 2026-04-16
Germany Conclusion Of Non-exclusive Discount Agreements In Accordance With Section 130a Paragraph. 8 Sgb V On The Active Ingredients Mentioned With The Possibility Of Contracting Within The Framework Of The So-called Openhouse Procedure. 2026-04-16
Germany Conclusion Of Non-exclusive Discount Agreements In Accordance With Section 130a Paragraph 8 Sgb V For The Active Ingredients Mentioned With The Possibility Of Conclusion Within The Framework Of The So-called Open House Procedure. 2026-04-16
Sweden Conventional X-ray With Fluoroscopy - Request For Information (rfi) 2026-04-16
Germany Care Prevention 2026-04-16
Sweden Rfi And Invitation To Hearing - Regional Anesthesia 2026-04-16
United Kingdom Stoma Care Nurse Sponsorship 2026-04-16
Whats app